Stay updated with breaking news from Bleeding Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Sobi® today announced that the US Food and Drug Administration (FDA) has approved efanesoctocog alfa [Antihemophilic Factor (Recombinant),...
FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection Paris and Stockholm – February 23, 2023 – The U.S. Food and Drug Administration (FDA) has approved ALTUVIIIO™ [Antihemophilic Factor (Recombinant), Fc-V...
Investegate announcements from Sanofi - Aventis Groupe, Press Release: FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection
FDA approves once-weekly ALTUVIIIO, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection Paris and Stockholm - February 23
LAGOS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research has recently published a Report, titled, " Shingles Treatment Market " The report offers an extensive analysis of key growth strategies, drivers, opportunities, key se...